TickerCurrent Price% Daily ChangeVolume (1,000s)Average Volumn (1,000s)Market Cap (Millions)1/2/2024 Price% Change Since Inception 1/2/2024

Contact Information

MIRA Pharmaceuticals, Inc.
855 North Wolfe Street
Suite 601
Baltimore, MD 21205
United States

Mira Pharmaceuticals

Developing the next-generation FDA-approved novel synthetic THC analog

MIRA1a is being developed to treat anxiety and cognitive decline in the elderly and neuropathic pain without impurities or the adverse side effects of cannabis plant extracts.